National Bank of Canada
ARNA

National Bank of Canada’s Arena Pharmaceuticals Inc ARNA Stock Holding History

National Bank of Canada’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-215
Closed -$20K – 3112
2021
Q4 		$20K Buy
+215
New +$14.2K ﹤0.01% 2172

National Bank of Canada's ARNA Position: Q1 2022 in Review

National Bank of Canada sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 215 shares — an estimated $20K sold.

National Bank of Canada first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $20K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • National Bank of Canada reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • National Bank of Canada sold 215 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $20K.
  • National Bank of Canada first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
  • National Bank of Canada's Arena Pharmaceuticals Inc position peaked at $20K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on National Bank of Canada's 13F filing for Q1 2022, filed 5 May 2022.